Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome.

Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome.

Item
http://www.wikidata.org/entity/Q40556204
Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PETCancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse modelsMolecular imaging of cell death in tumors. Increasing annexin A5 size reduces contribution of phosphatidylserine-targeting function to tumor uptake.Personalised medicine for cancer: from drug development into clinical practice.The application of microbubbles for targeted drug delivery.Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery.Measuring response to therapy by near-infrared imaging of tumors using a phosphatidylserine-targeting antibody fragment.Preclinical imaging of therapy response using metabolic and apoptosis molecular imaging.Bioluminescence imaging of therapy response does not correlate with FDG-PET response in a mouse model of Burkitt lymphoma
P2860

Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome.

Item
http://www.wikidata.org/entity/Q40556204
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Multi-modality imaging identif ...... dictor of therapeutic outcome.
@en
type
label
Multi-modality imaging identif ...... dictor of therapeutic outcome.
@en
prefLabel
Multi-modality imaging identif ...... dictor of therapeutic outcome.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Multi-modality imaging identif ...... dictor of therapeutic outcome.
@en
P2093
P304
P31
P356
10.1162/153535004773861679
P433
P478
P50
P577
P698